## Partial Heart Transplantation: A Novel Approach to Congenital Heart Disease – 2025 Update
Did You Know? As of September 26, 2025, partial heart transplantation remains a relatively uncommon procedure, performed in specialized centers globally. Recent advancements in preservation techniques are expanding its potential reach.
The landscape of congenital heart disease (CHD) treatment is continually evolving, and a promising, yet less widely known, technique – partial heart transplantation – is gaining traction as a viable option for select pediatric patients. This innovative procedure, detailed in a recent study published in JAMA by Overbey and colleagues (september 23, 2025), offers a lifeline for children requiring aortic and/or pulmonary valve replacement. Instead of a full heart transplant, this approach utilizes valves and great vessels sourced from deceased donors or “domino” transplants, offering a targeted solution for specific cardiac defects. This article delves into the intricacies of partial heart transplantation, examining its methodology, outcomes, and future potential, providing a comprehensive overview for both medical professionals and informed patients.
### Understanding Partial Heart Transplantation: A Detailed Examination
Traditionally, children with severe valve dysfunction stemming from CHD often faced the prospect of full heart transplantation – a complex procedure with meaningful logistical and immunological challenges. Partial heart transplantation, though, presents a less invasive alternative. The core principle involves procuring a functional heart valve and the associated great vessels (aorta and/or pulmonary artery) from a donor heart deemed unsuitable for full transplantation. This can occur in two primary scenarios: from a deceased donor whose entire heart isn’t viable for a full transplant, or through a “domino” transplant.
Pro Tip: Domino transplants, where a patient receives a new heart and a viable valve from their explanted organ is then used for another patient, maximize donor organ utilization and reduce waitlist times.
A domino transplant occurs when a patient receives a full heart transplant, and their native, but failing, heart contains a healthy valve. This valve can then be harvested and utilized for a partial heart transplant in another patient. The harvested valve is meticulously preserved in a specialized storage solution at 4°C, maintaining its viability for up to 75 hours – a critical window for successful implantation. This preservation period allows for careful matching and logistical coordination. Recent research, including a study published in the *Journal of Thoracic and Cardiovascular Surgery* (August 2025), highlights the efficacy of University of Wisconsin (UW) solution and histidine-tryptophan-ketoglutarate (HTK) solution in extending preservation times while minimizing ischemic damage.
### Outcomes and Immunological Considerations: The Overbey Study and Beyond
The JAMA study, conducted as a retrospective analysis at a single pediatric center, followed 19 children who underwent partial heart transplantation for congenital heart disease.The results are encouraging. Researchers observed excellent valve function in the majority of patients,with outflow gradients consistently below 15 mm Hg and minimal valve leakage (no more than mild regurgitation). Importantly, the implanted valves demonstrated appropriate growth alongside the child, accommodating their developing anatomy at a median follow-up of 26 weeks.
Post-transplant, patients received a standard immunosuppression regimen, typically involving tacrolimus and mycophenolate mofetil, to prevent rejection of the donor valve.Immunosuppression management is crucial, balancing the need to prevent rejection with the risks of infection and other side effects. The Overbey study reported a relatively low rate of reoperation – only two patients required additional surgical intervention. One case involved the correction of a previously undetected vascular ring, and the other addressed supravalvar pulmonary stenosis caused by calcification of cryopreserved homograft material used in conjunction with the partial heart transplant.
Key Facts: Partial Heart Transplantation vs. Full Heart Transplantation
| Feature | Partial Heart Transplantation | Full Heart Transplantation |
|---|---|---|
| Donor Organ | Valve & Great Vessels | Entire Heart |
| Surgical Complexity | Generally Less Invasive | Highly Complex |
| Immunosuppression | Required | Required |
| Waitlist Time | Possibly Shorter | Often Prolonged |
| donor Availability | Increased Utilization of Donors |